Fragment Informatics and Computational Fragment-Based Drug Design: An Overview and Update-Reference-Cited by-同舟云学术

Fragment Informatics and Computational Fragment-Based Drug Design: An Overview and Update

Published:2012-03-19 Issue:3 Volume:33 Page:554-598
ISSN:0198-6325
Container-title:Medicinal Research Reviews
language:en
Short-container-title:Med. Res. Rev.

Author:

Sheng Chunquan¹,Zhang Wannian¹

Affiliation:

1. Department of Medicinal Chemistry; School of Pharmacy; Second Military Medical University; 325 Guohe Road Shanghai 200433 People's Republic of China

Publisher

Wiley

Subject

Drug Discovery,Pharmacology,Molecular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/med.21255/fullpdf

Reference267 articles.

1. Novel trends in high-throughput screening;Mayr;Curr Opin Pharmacol,2009

2. The art and practice of structure-based drug design: A molecular modeling perspective;Bohacek;Med Res Rev,1996

3. High-throughput drug discovery: What can we expect from HTS?;Gribbon;Drug Discov Today,2005

4. A decade of fragment-based drug design: Strategic advances and lessons learned;Hajduk;Nat Rev Drug Discov,2007

5. Discovering high-affinity ligands for proteins: SAR by NMR;Shuker;Science,1996

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fragment-based Drug Discovery Strategy and its Application to the Design of SARS-CoV-2 Main Protease Inhibitor;Current Medicinal Chemistry;2024-11

2. Advanced technologies for screening and identifying covalent inhibitors;TrAC Trends in Analytical Chemistry;2024-09

3. Identification of Marine-Derived SLC7A11 Inhibitors: Molecular Docking, Structure-Based Virtual Screening, Cytotoxicity Prediction, and Molecular Dynamics Simulation;Marine Drugs;2024-08-20

4. Equivariant 3D-conditional diffusion model for molecular linker design;Nature Machine Intelligence;2024-04-11

5. Review of the impact of fragment-based drug design on PROTAC degrader discovery;TrAC Trends in Analytical Chemistry;2024-02